FENNEC PHARMACEUTICALS INC. Severance Costs
FENNEC PHARMACEUTICALS INC. (FENC) reported Severance Costs of $0 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2014-11-13
- FENNEC PHARMACEUTICALS INC. severance costs for the quarter ending 2014-09-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. severance costs for the quarter ending 2014-06-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. severance costs for the quarter ending 2014-03-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. severance costs for the quarter ending 2013-12-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. severance costs for fiscal 2013 was $0.00.
- FENNEC PHARMACEUTICALS INC. severance costs for fiscal 2012 was $0.00.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month | Severance Costs 202 month | Severance Costs 205 month | Severance Costs 208 month | Severance Costs 211 month | Severance Costs 214 month | Severance Costs 217 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $168.00K 10-Q · filed 2014-11-13 | |||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $168.00K 10-Q · filed 2014-08-11 | |||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $168.00K 10-Q · filed 2014-05-15 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $0.00 10-K · filed 2014-03-31 | $168.00K 10-K · filed 2014-03-31 | |||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $168.00K 10-Q · filed 2013-11-18 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-08-11 | $168.00K 10-Q · filed 2013-08-09 | |||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | ||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-18 | $0.00 derived: sum of 2 quarters · filed 2013-11-18 | $0.00 10-Q · filed 2013-11-18 | |||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |